Zhang Meng-Xian, Han Na, Yu Shi-Ying, Leng Yan
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):325-9.
To construct a CXCR4 specific recombinant plasmid vector and study its inhibiting effect on invasion capacity in vitro of human breast cancer MDA-MB-231 cell line and its metastatic potential to the lung in nude mice.
A CXCR4 specific recombinant plasmid vector was constructed and transfected into the cultured MDA-MB-231 cell line with lipofectamine 2000. RT-PCR and Western blot were used to detect the mRNA and protein expression of CXCR4, respectively. Invasion capability in vitro of the cells was evaluated by Boyden chamber. The cell proliferation capacity was detected by MTT method. The nude mouse model of lung metastasis was established by injection of MDA-MB-231 cells into the tail vein. The animals were sacrificed at 6 weeks after the tumor cells injection. Whole lung tissues were harvested, embedded in paraffin, sectioned serially, and the HE-stained paraffin sections were examined pathologically to evaluate the presence and number of metastatic tumors.
The CXCR4 mRNA expression rate was 29.5% +/- 3.8% in the CXCR4-shRNA group, significantly lower than that of the control group (69.7% +/- 2.6%, P < 0.01) and mock-control group (67.8% +/- 3.5%, P < 0.01). The CXCR4 protein expression rate was 15.4% +/- 1.1% in the CXCR4-shRNA group, significantly lower than that of the control group (39.0% +/- 2.4%, P < 0.01) and mock-control group (35.9% +/- 3.9%, P < 0.01). Silencing of CXCR4 by shRNA lead to a significant decrease in breast cancer cell invasion and proliferation capacity in vitro. Furthermore, tumor cells with CXCR4 shRNA permanent transfcetion had a much lower lung metastatic potential in nude mice than control cells and mock control cells in vivo.
CXCR4 shRNA can inhibit the expression of CXCR4 and decrease the invasion and lung metastatic potential of human breast cancer cells.
构建CXCR4特异性重组质粒载体,研究其对人乳腺癌MDA-MB-231细胞系体外侵袭能力及对裸鼠肺转移潜能的抑制作用。
构建CXCR4特异性重组质粒载体,用脂质体2000转染培养的MDA-MB-231细胞系。分别采用RT-PCR和Western blot检测CXCR4的mRNA和蛋白表达。采用Boyden小室评估细胞的体外侵袭能力。采用MTT法检测细胞增殖能力。通过尾静脉注射MDA-MB-231细胞建立肺转移裸鼠模型。在注射肿瘤细胞6周后处死动物。收集全肺组织,石蜡包埋,连续切片,对苏木精-伊红染色的石蜡切片进行病理检查,以评估转移瘤的存在情况和数量。
CXCR4-shRNA组CXCR4 mRNA表达率为29.5%±3.8%,显著低于对照组(69.7%±2.6%,P<0.01)和空载体对照组(67.8%±3.5%,P<0.01)。CXCR4-shRNA组CXCR4蛋白表达率为15.4%±1.1%,显著低于对照组(39.0%±2.4%,P<0.01)和空载体对照组(35.9%±3.9%,P<0.01)。shRNA沉默CXCR4导致乳腺癌细胞体外侵袭和增殖能力显著降低。此外,在体内,CXCR4 shRNA永久转染的肿瘤细胞在裸鼠中的肺转移潜能远低于对照细胞和空载体对照细胞。
CXCR4 shRNA可抑制CXCR4表达,降低人乳腺癌细胞的侵袭和肺转移潜能。